Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 4/20 | 0.40 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.38 |
| ▸ | KMO | O15229 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.34 |
| ▸ | RORB | Q92753 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5700591 | 0.89 | — | — | |
| SCHEMBL1476650 | 0.76 | GRM5 (0.42) | — | |
| SCHEMBL4231834 | 0.72 | MYC (0.46) | KMO | |
| SCHEMBL3257645 | 0.70 | MAP4K4 (0.36) | MAP4K4KMOPLK1 | |
| SCHEMBL1642974 | 0.70 | ESR1 (0.35) | LRRK2 | |
| SCHEMBL2520704 | 0.70 | BIRC5 (0.32) | — | |
| SCHEMBL1644273 | 0.70 | GRM4 (0.47) | MAP4K4KMO | |
| SCHEMBL14976487 | 0.69 | MAP4K4 (0.31) | MAP4K4KMO | |
| SCHEMBL1477713 | 0.69 | RORB (0.37) | ALOX5RORB | |
| SCHEMBL3849043 | 0.69 | PIM1 (0.53) | MAP4K4KMOPIM1IDO1PLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283476-B2 | Transition metal catalyzed synthesis of 2H-indazoles | SANOFI (FR) | 2012-10-09 | — | — | US | disclosed |
| EP-2134682-B1 | A TRANSITION METAL CATALYZED SYNTHESIS OF N-AMINOINDOLES | SANOFI SA (FR) | 2011-12-14 | — | — | EP | disclosed |
| US-8026375-B2 | Transition metal catalyzed synthesis of N-aminoindoles | SANOFI-AVENTIS (FR) | 2011-09-27 | — | — | US | disclosed |
| EP-2170833-B1 | A TRANSITION METAL CATALYZED SYNTHESIS OF 2H-INDAZOLES | SANOFI AVENTIS (FR) | 2011-06-01 | — | — | EP | disclosed |
| US-20100234601-A1 | Transition metal catalyzed synthesis of 2H-indazoles | SANOFI-AVENTIS (FR) | 2010-09-16 | — | — | US | disclosed |
| US-20100168429-A1 | Transition metal catalyzed synthesis of N-aminoindoles | SANOFI-AVENTIS (FR) | 2010-07-01 | — | — | US | disclosed |
| EP-2170833-A1 | A TRANSITION METAL CATALYZED SYNTHESIS OF 2H-INDAZOLES | Sanofi-Aventis (FR) | 2010-04-07 | — | — | EP | disclosed |
| EP-2134682-A1 | A TRANSITION METAL CATALYZED SYNTHESIS OF N-AMINOINDOLES | Sanofi-Aventis (FR) | 2009-12-23 | — | — | EP | disclosed |
| WO-2009000411-A1 | A TRANSITION METAL CATALYZED SYNTHESIS OF 2H-INDAZOLES | SANOFI-AVENTIS (FR) | 2008-12-31 | — | — | WO | disclosed |
| WO-2008125207-A1 | A TRANSITION METAL CATALYZED SYNTHESIS OF N-AMINOINDOLES | SANOFI-AVENTIS (FR) | 2008-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168429-A1 | Transition metal catalyzed synthesis of N-aminoindoles | NAT1, H1-3, H1-2 | MAP4K4 3181/4885NUDT1 431/4885KMO 310/4885 |
| US-20100234601-A1 | Transition metal catalyzed synthesis of 2H-indazoles | H1-3, H1-2, H1-4 | MAP4K4 2379/4885NUDT1 548/4885KMO 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.